Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Protocol H8K-MC-JZAO A Randomized Phase 3 Study of Tasisulam Administered as an Intravenous Infusion on Day 1 of a 28 Day Cycle vs. Paclitaxel as Seco


Collapse Overview 
Collapse sponsor award id
H8K-MC-JZAO


Collapse Biography 

Collapse Time 
Collapse start date
2010-04-05